XML 33 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Cash flows from operating activities:    
Net income $ 153,151,000 $ 152,729,000
Adjustments to reconcile net income to net cash used by operating activities:    
Depreciation and amortization 33,322,000 31,277,000
Stock-based compensation expense 17,426,000 14,649,000
Impairment of right of use assets 0 7,392,000
Impairment of fixed assets 0 1,915,000
Provision for doubtful accounts 11,018,000 9,629,000
Gain on cash surrender value of life insurance policies (4,890,000) (2,184,000)
Loss (gain) on marketable securities 9,691,000 (10,041,000)
Deferred income taxes (817,000) 3,006,000
Change in other assets and liabilities:    
Deferred compensation 18,871,000 30,339,000
Receivables due from clients (71,747,000) (169,037,000)
Income taxes and other receivables (12,220,000) (1,588,000)
Prepaid expenses and other assets (4,209,000) (6,330,000)
Unearned compensation (5,785,000) (44,955,000)
Income taxes payable (6,582,000) (1,832,000)
Accounts payable and accrued liabilities (235,729,000) (56,852,000)
Other (218,000) (641,000)
Net cash used in operating activities (98,718,000) (42,524,000)
Cash flows from investing activities:    
Cash paid for acquisitions, net of cash acquired (99,322,000) 0
Purchase of marketable securities (52,085,000) (54,070,000)
Proceeds from sales/maturities of marketable securities 37,186,000 38,725,000
Purchase of property and equipment (36,867,000) (18,988,000)
Proceeds from life insurance policies 1,050,000 3,163,000
Premium on company-owned life insurance policies (289,000) (295,000)
Dividends received from unconsolidated subsidiaries 150,000 195,000
Net cash used in investing activities (150,177,000) (31,270,000)
Cash flows from financing activities:    
Repurchases of common stock (56,891,000) (9,386,000)
Payments of tax withholdings on restricted stock (22,060,000) (18,058,000)
Proceeds from issuance of common stock upon exercise of employee stock options and in connection with an employee stock purchase plan 4,371,000 3,593,000
Dividends paid to shareholders (16,874,000) (13,549,000)
Dividends - noncontrolling interest (3,133,000) 0
Principal payments on finance leases (814,000) (592,000)
Payments on life insurance policy loans (662,000) (64,000)
Net cash used in financing activities (96,063,000) (38,056,000)
Effect of exchange rate changes on cash and cash equivalents (39,212,000) (13,537,000)
Net decrease in cash and cash equivalents (384,170,000) (125,387,000)
Cash and cash equivalents at beginning of period 978,070,000 850,778,000
Cash and cash equivalents at end of the period $ 593,900,000 $ 725,391,000